Advisors Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,310
Closed -$627K 1631
2019
Q3
$627K Sell
6,310
-2,433
-28% -$231K 0.01% 910
2019
Q2
$808K Sell
8,743
-549
-6% -$52.1K 0.01% 858
2019
Q1
$877K Sell
9,292
-8,204
-47% -$717K 0.02% 865
2018
Q4
$1.12M Sell
17,496
-11,129
-39% -$822K 0.02% 722
2018
Q3
$2.56M Sell
28,625
-13,188
-32% -$1.17M 0.04% 515
2018
Q2
$3.32M Sell
41,813
-16,121
-28% -$1.34M 0.06% 407
2018
Q1
$5.05M Sell
57,934
-16,465
-22% -$1.58M 0.08% 310
2017
Q4
$7.76M Sell
74,399
-1,224
-2% -$138K 0.13% 197
2017
Q3
$11M Sell
75,623
-6,779
-8% -$923K 0.18% 141
2017
Q2
$10.7M Buy
82,402
+6,989
+9% +$856K 0.18% 145
2017
Q1
$9.38M Buy
75,413
+4,674
+7% +$559K 0.16% 176
2016
Q4
$8.19M Buy
70,739
+7,401
+12% +$824K 0.14% 206
2016
Q3
$6.62M Sell
63,338
-709
-1% -$76.7K 0.11% 276
2016
Q2
$6.32M Buy
64,047
+8,173
+15% +$845K 0.1% 294
2016
Q1
$5.59M Sell
55,874
-2,257
-4% -$232K 0.09% 313
2015
Q4
$6.96M Sell
58,131
-24,985
-30% -$2.89M 0.11% 257
2015
Q3
$8.99M Buy
83,116
+4,802
+6% +$596K 0.14% 199
2015
Q2
$9.06M Buy
78,314
+319
+0.4% +$36.5K 0.12% 226
2015
Q1
$8.99M Sell
77,995
-14,388
-16% -$1.72M 0.12% 219
2014
Q4
$10.3M Sell
92,383
-6,085
-6% -$642K 0.14% 190
2014
Q3
$9.33M Sell
98,468
-9,106
-8% -$822K 0.13% 206
2014
Q2
$9.24M Buy
107,574
+7,366
+7% +$560K 0.13% 212
2014
Q1
$7M Buy
100,208
+13,666
+16% +$1.08M 0.11% 241
2013
Q4
$7.31M Buy
86,542
+16,382
+23% +$1.3M 0.12% 226
2013
Q3
$5.4M Buy
70,160
+16,990
+32% +$1.19M 0.1% 272
2013
Q2
$3.11M Buy
+53,170
New +$3.2M 0.06% 375

Other funds holding CELG

Advisors Asset Management's CELG Position: Q4 2019 in Review

Advisors Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,310 shares — an estimated $627K sold.

Advisors Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $11M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Advisors Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Advisors Asset Management sold 6,310 Celgene Corp shares in Q4 2019, an estimated $627K.
  • Advisors Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Advisors Asset Management's Celgene Corp position peaked at $11M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Advisors Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.